TCR2 Therapeutics (TCRR) PT Lowered to $23 at Piper Sandler

March 22, 2022 11:51 AM EDT
Get Alerts TCRR Hot Sheet
Price: $2.89 -0.34%

Rating Summary:
    7 Buy, 3 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 1 | Down: 0 | New: 0
Join SI Premium – FREE
Piper Sandler analyst Do Kim lowered the price target on TCR2 Therapeutics (NASDAQ: TCRR) to $23.00 (from $26.00) while maintaining a Overweight rating.

You May Also Be Interested In





Related Categories

Analyst PT Change